Literature DB >> 19656495

DNA vaccines expressing retrovirus-like particles are efficient immunogens to induce neutralizing antibodies.

Bertrand Bellier1, Christophe Huret, Mathilde Miyalou, Delphine Desjardins, Marie-Pascale Frenkiel, Philippe Despres, Fréderic Tangy, Charlotte Dalba, David Klatzmann.   

Abstract

We aimed at improving DNA vaccination efficiency for inducing neutralizing antibodies. We used plasmids encoding Gag of MLV and envelope proteins of VSV or WNV. Upon in vivo injection, they generate retrovirus-derived VLPs pseudotyped with these envelopes expressed in their wild-type conformation. We show that these plasmo-retroVLPs induce potent humoral responses, the efficacy of which could be improved by co-administration of DNA encoding adjuvant cytokines. Antibodies against VSV or WNV were detected earlier than with plasmids not generating VLPs, and had higher neutralizing activities. These results highlight the potential of this approach for vaccination strategies aiming at neutralizing antibody induction.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19656495     DOI: 10.1016/j.vaccine.2009.07.059

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  15 in total

Review 1.  Nanovaccines for cancer immunotherapy.

Authors:  Yu Zhang; Shuibin Lin; Xiang-Yang Wang; Guizhi Zhu
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2019-06-06

2.  Retrovirus-Based Virus-Like Particle Immunogenicity and Its Modulation by Toll-Like Receptor Activation.

Authors:  Fabien Pitoiset; Thomas Vazquez; Beatrice Levacher; Djamel Nehar-Belaid; Nicolas Dérian; James Vigneron; David Klatzmann; Bertrand Bellier
Journal:  J Virol       Date:  2017-10-13       Impact factor: 5.103

3.  Intranasal DNA vaccination induces potent mucosal and systemic immune responses and cross-protective immunity against influenza viruses.

Authors:  Lea Torrieri-Dramard; Bénédicte Lambrecht; Helena Lage Ferreira; Thierry Van den Berg; David Klatzmann; Bertrand Bellier
Journal:  Mol Ther       Date:  2010-10-19       Impact factor: 11.454

4.  Immunogenicity and safety of virus-like particle of the porcine encephalomyocarditis virus in pig.

Authors:  Hye-Young Jeoung; Won-Ha Lee; WooSeog Jeong; Bo-Hye Shin; Hwan-Won Choi; Hee Soo Lee; Dong-Jun An
Journal:  Virol J       Date:  2011-04-15       Impact factor: 4.099

5.  Induction of humoral and cellular immune responses against the HIV-1 envelope protein using γ-retroviral virus-like particles.

Authors:  Tea Kirkegaard; Adam Wheatley; Jesper Melchjorsen; Shervin Bahrami; Finn S Pedersen; Robert J Center; Damian F J Purcell; Lars Ostergaard; Mogens Duch; Martin Tolstrup
Journal:  Virol J       Date:  2011-08-01       Impact factor: 4.099

6.  Induction of ebolavirus cross-species immunity using retrovirus-like particles bearing the Ebola virus glycoprotein lacking the mucin-like domain.

Authors:  Wu Ou; Josie Delisle; Jerome Jacques; Joanna Shih; Graeme Price; Jens H Kuhn; Vivian Wang; Daniela Verthelyi; Gerardo Kaplan; Carolyn A Wilson
Journal:  Virol J       Date:  2012-01-25       Impact factor: 4.099

Review 7.  Preclinical Development and Production of Virus-Like Particles As Vaccine Candidates for Hepatitis C.

Authors:  Makutiro Ghislain Masavuli; Danushka K Wijesundara; Joseph Torresi; Eric J Gowans; Branka Grubor-Bauk
Journal:  Front Microbiol       Date:  2017-12-05       Impact factor: 5.640

8.  A recombinant novirhabdovirus presenting at the surface the E Glycoprotein from West Nile Virus (WNV) is immunogenic and provides partial protection against lethal WNV challenge in BALB/c mice.

Authors:  Angella Nzonza; Sylvie Lecollinet; Sophie Chat; Steeve Lowenski; Emilie Mérour; Stéphane Biacchesi; Michel Brémont
Journal:  PLoS One       Date:  2014-03-24       Impact factor: 3.240

9.  Different immunogenicity but similar antitumor efficacy of two DNA vaccines coding for an antigen secreted in different membrane vesicle-associated forms.

Authors:  Christine Sedlik; James Vigneron; Lea Torrieri-Dramard; Fabien Pitoiset; Jordan Denizeau; Caroline Chesneau; Philippe de la Rochere; Olivier Lantz; Clotilde Thery; Bertrand Bellier
Journal:  J Extracell Vesicles       Date:  2014-08-27

10.  Early Transcriptome Signatures from Immunized Mouse Dendritic Cells Predict Late Vaccine-Induced T-Cell Responses.

Authors:  Nicolas Dérian; Bertrand Bellier; Hang Phuong Pham; Eliza Tsitoura; Dorothea Kazazi; Christophe Huret; Penelope Mavromara; David Klatzmann; Adrien Six
Journal:  PLoS Comput Biol       Date:  2016-03-21       Impact factor: 4.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.